Victrex (LON: VCT)‘s stock had its “hold” rating reaffirmed by equities researchers at Numis Securities Ltd in a report issued on Thursday. They currently have a $22.50 (1400 GBX) price target on the stock.

A number of other firms have also recently commented on VCT. Analysts at JPMorgan Chase upgraded shares of Victrex to a “neutral” rating in a research note to investors on Thursday, September 6th. They now have a $18.41 price target on the stock. Analysts at Main First Bank AG reiterated a “neutral” rating on shares of Victrex in a research note to investors on Wednesday, August 29th. They now have a $22.22 price target on the stock.

Victrex opened at 1395.00 on Thursday. Victrex has a 1-year low of GBX 1037.00 and a 1-year high of GBX 1526.00. The company’s market cap is £1.169 billion.

Victrex plc is engaged in the manufacturing and selling of high performance polymers. The Company’s business is organized as two business units: Victrex Polymer Solutions (VPS) and Invibio Biomaterial Solutions (Invibio).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.